Science & academia

This archive covers milestones and breakthroughs from the scientific and academic world — researchers, universities, and institutions whose work advances human knowledge. Stories here highlight discoveries, studies, and scholarly efforts that point toward a better future.

A neuron or nerve cell is an electrically excitable cell, for article on ALS synapse-regenerating pill

Breakthrough synapse-regenerating ALS pill moves to phase 2 human trials

By / / Good News For Humankind

A once-daily ALS pill designed to rebuild neural connections — not just slow their loss — has cleared FDA approval to begin Phase 2 trials, with patients across the U.S. starting doses in April 2024. SPG302 works on synapses, the tiny junctions where neurons talk to each other, which start vanishing before motor neurons themselves die. Every ALS drug currently on the market aims to slow decline; this one is being tested for whether it can actually help recover lost function. For the roughly 30,000 Americans living with ALS, that’s a genuinely different question to be asking. If it works, it could reshape how researchers approach neurodegenerative disease far beyond ALS.

A rainforest river winding through dense green jungle in Suriname for an article about Suriname malaria-free certification, for article on dual-insecticide bed nets

New types of mosquito bed nets could cut malaria risk by up to half, trial finds

By / / Good News For Humankind

New mosquito bed nets cut malaria transmission by 20 to 50 percent in a major trial across 17 African countries, offering a real answer to the growing problem of insecticide resistance. The nets pair the standard pyrethroid coating with a second insecticide that hits mosquitoes through a different biological pathway, so the ones that used to shrug off treated nets no longer can. At under three dollars each, they cost about the same as the older versions they’re replacing. Paired with the malaria vaccine now rolling out across Africa, these nets are part of a layered defense that could meaningfully shift the trajectory of a disease that still kills hundreds of thousands of people every year.

A medical professional drawing blood from a patient's arm for an article about blood tests for dementia, for article on dementia blood test

U.K. launches blood tests for dementia in landmark five-year trial

By / / Good News For Humankind

Dementia blood tests are now being offered at more than 50 memory clinics across the U.K., in a landmark five-year trial aiming to transform how the disease is detected. Led by researchers at Oxford and University College London, the study will screen approximately 5,000 volunteers for protein biomarkers linked to Alzheimer’s and other forms of dementia. Currently, around one in three people with dementia in England has never received a formal diagnosis, and painful, slow pathways mean some patients wait up to four years for results. Earlier detection could connect patients to newer treatments that work best in the disease’s earliest stages.

Elderly person smiling, for article on global life expectancy gains

Global life expectancy increased by 6.2 years between 1990 and 2021

By / / Good News For Humankind

Global life expectancy rose by 6.2 years between 1990 and 2021, according to a sweeping Lancet study built from over 607 billion estimates by researchers at the Institute for Health Metrics and Evaluation. The biggest leap came in Eastern sub-Saharan Africa, where people gained 10.7 years of life, largely thanks to clean water, vaccines, and oral rehydration therapy beating back diarrheal diseases. Steep drops in lower respiratory infections, stroke, and heart disease added further years almost everywhere. The pandemic set things back, but the deeper story is hopeful: targeted public health investment works at scale, and extending those same tools to every country is now the defining frontier of global health.

Mushrooms, for article on psilocybin public opinion

Nearly 9 in 10 Americans now think using psilocybin is ‘morally positive,’ in dramatic shift in public opinion

By / / Good News For Humankind

Supervised psilocybin therapy just got a remarkable vote of confidence: in a new peer-reviewed survey of 795 U.S. adults, 91% of liberals and 86% of conservatives called its use for psychiatric treatment morally acceptable. That’s the kind of bipartisan agreement you almost never see anymore. Researchers from Oxford, Yale, Johns Hopkins, and Granada also found that strong majorities approved of psilocybin to enhance well-being in healthy people, not just to treat illness. The authors suggest compassion-based values help explain the consensus across political lines. As more states move toward legal, supervised psilocybin services, this quiet agreement among Americans hints at a broader, more humane shift in how societies might soon approach mental health.

Woman receiving mammogram, for article on U.K. cancer mortality drop

Cancer deaths in middle-aged people in the U.K. have plummeted since the 1990s

By / / Good News For Humankind

Cancer deaths among middle-aged adults in the U.K. have dropped by more than a third over 25 years, according to a new Cancer Research U.K. study tracking 23 cancer types. Cervical cancer mortality led the way with a 54% fall, thanks largely to national screening programmes, while lung cancer deaths in men plummeted by 53% as smoking rates declined. Behind the statistics are people like Anne Parmenter, whose bowel cancer was caught through a routine NHS screening kit that arrived in the post — nine years later, she credits it with saving her life. For countries investing in tobacco control, HPV vaccination, or expanded screening, the U.K.’s quarter-century record offers something powerful: evidence that patient, sustained public health work genuinely saves lives.

3d illustration of gut and stomach pain, for article on Crohn's disease remission

79% of Crohn’s disease patients in remission after early intervention

By / / Good News For Humankind

Crohn’s disease patients given the drug infliximab right after diagnosis reached sustained remission at a rate of 79% after one year, compared to just 15% for those on the standard step-by-step approach. The Cambridge-led trial of 386 patients also found that only one person in the early-treatment group needed urgent bowel surgery, versus ten in the conventional group. Researchers say the old wisdom of saving the strongest drugs for last lets quiet damage build up while the clock ticks. With cheaper biosimilar versions now widely available, this finding could reshape care for the millions living with Crohn’s worldwide — and it’s a powerful reminder that sometimes the best medicine is simply not waiting.

Solar panels, for article on utility-scale solar farm, for article on Pacific renewable energy, for article on dome-shaped solar cells

Turkish scientists develop “bumpy” solar panel concept that can harvest up to 66% more energy

By / / Good News For Humankind

Dome-shaped solar cells could absorb up to 66% more light than their flat counterparts, according to new simulations from a research team at Abdullah Gül University in Türkiye. The trick is geometric: tiny hemispherical bumps catch sunlight from many angles at once, acting almost like little lenses that funnel light into the cell. That means solar power could finally work well on surfaces that flat panels struggle with, like clothing, curved windows, greenhouse roofs, and wearable medical devices. The design still needs to be built and tested in the real world, but it points toward a future where solar generation lives quietly inside the everyday surfaces around us, rather than only on dedicated rooftops.

Dentist's Hand Taking Saliva Test From Woman's Mouth, for article on handheld saliva test for breast cancer

Hand-held test for breast cancer uses your saliva and gives accurate readings in 5 seconds

By / / Good News For Humankind

A handheld breast cancer screener developed by researchers in the U.S. and Taiwan can detect cancer biomarkers from a single drop of saliva in under five seconds — using a reusable circuit board that costs just $5 and paper test strips priced in pennies. Built on the same glucose-strip technology found in home diabetes kits, the device was designed specifically for clinics and communities where mammograms and MRIs aren’t an option. Lead author Hsiao-Hsuan Wan said the goal was to make screening possible where it simply hasn’t been before. Clinical trials and approvals still lie ahead, but if it gets there, early detection — one of medicine’s most powerful tools against breast cancer — could finally reach the millions of women long left out.

A researcher examining lung cancer scans in a clinical setting for an article about mesothelioma survival rates, for article on mesothelioma survival rates

New drug quadruples three-year survival rates for mesothelioma in international trial

By / / Good News For Humankind

Mesothelioma survival rates have quadrupled over three years thanks to a drug that starves tumors of a key nutrient, marking the first successful new treatment combination for the disease in 20 years. The international ATOMIC-meso trial, led by Queen Mary University of London and published in JAMA Oncology, found that patients receiving pegargiminase alongside standard chemotherapy were significantly more likely to be alive three years later. The drug works by depleting arginine in the bloodstream, cutting off a nutrient that mesothelioma cells cannot produce themselves. For a cancer caused by asbestos exposure that has historically offered patients months rather than years, this breakthrough represents a genuine turning point.